These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 27081259)
1. Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities. Lim ZV; Oon HH Ann Dermatol; 2016 Apr; 28(2):147-51. PubMed ID: 27081259 [TBL] [Abstract][Full Text] [Related]
2. Hidradenitis suppurativa and associated diseases. Pescitelli L; Ricceri F; Prignano F G Ital Dermatol Venereol; 2018 Jun; 153(3 Suppl 2):8-17. PubMed ID: 30468375 [TBL] [Abstract][Full Text] [Related]
3. Association of metabolic syndrome and hidradenitis suppurativa. Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996 [TBL] [Abstract][Full Text] [Related]
4. Comorbidities of hidradenitis suppurativa. Porter ML; Kimball AB Semin Cutan Med Surg; 2017 Jun; 36(2):55-57. PubMed ID: 28538744 [TBL] [Abstract][Full Text] [Related]
5. Hidradenitis suppurativa and the metabolic syndrome. Ergun T Clin Dermatol; 2018; 36(1):41-47. PubMed ID: 29241751 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. Gold DA; Reeder VJ; Mahan MG; Hamzavi IH J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875 [TBL] [Abstract][Full Text] [Related]
7. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis. Scheinfeld N Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308 [TBL] [Abstract][Full Text] [Related]
8. Systemic associations of hidradenitis suppurativa. Kohorst JJ; Kimball AB; Davis MD J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S27-35. PubMed ID: 26470611 [TBL] [Abstract][Full Text] [Related]
9. What is hidradenitis suppurativa? Lee EY; Alhusayen R; Lansang P; Shear N; Yeung J Can Fam Physician; 2017 Feb; 63(2):114-120. PubMed ID: 28209676 [TBL] [Abstract][Full Text] [Related]
10. Co-morbidities in inflammatory dermatological diseases. Psoriasis, hidradenitis suppurativa, and cardiovascular risk factors. Miller IM Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324088 [TBL] [Abstract][Full Text] [Related]
11. Serum irisin level, insulin resistance, and lipid profiles in patients with hidradenitis suppurativa: a case-control study. Özkur E; Erdem Y; Altunay İK; Demir D; Dolu NÇ; Serin E; Çerman AA An Bras Dermatol; 2020; 95(6):708-713. PubMed ID: 33008659 [TBL] [Abstract][Full Text] [Related]
12. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa. Miller IM; McAndrew RJ; Hamzavi I Dermatol Clin; 2016 Jan; 34(1):7-16. PubMed ID: 26617352 [TBL] [Abstract][Full Text] [Related]
13. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. Shlyankevich J; Chen AJ; Kim GE; Kimball AB J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440 [TBL] [Abstract][Full Text] [Related]
14. Hidradenitis suppurativa and psoriasis: the odd couple. Macca L; Li Pomi F; Ingrasciotta Y; Morrone P; Trifirò G; Guarneri C Front Med (Lausanne); 2023; 10():1208817. PubMed ID: 37484864 [TBL] [Abstract][Full Text] [Related]
15. Management of hidradenitis suppurativa. Drug Ther Bull; 2016 Sep; 54(9):102-5. PubMed ID: 27585997 [TBL] [Abstract][Full Text] [Related]
16. The role of interleukin-17 in the pathogenesis of hidradenitis suppurativa. Yao Y; Thomsen SF Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469692 [TBL] [Abstract][Full Text] [Related]
17. Incidence, Risk Factors, and Prognosis of Hidradenitis Suppurativa Across the Globe: Insights from the Literature. Alotaibi HM Clin Cosmet Investig Dermatol; 2023; 16():545-552. PubMed ID: 36891064 [TBL] [Abstract][Full Text] [Related]